Abstract

Fibulin-2 (FBLN2) is a secreted extracellular matrix glycoprotein which has been associated with tissue development and remodelling. In the mouse mammary gland, FBLN2 can be detected during ductal morphogenesis in cap cells and myoepithelial cells at puberty and early pregnancy, respectively. In an attempt to assign its function, we knocked down Fbln2 in the mouse mammary epithelial cell line EpH4. FBLN2 reduction led to an increase in the size of spheroidal structures when compared to scrambled control shRNA-transduced cells plated on Matrigel matrix. This phenotype was associated with a disruption of the collagen IV sheath around the epithelial spheroids and downregulation of integrin β1, suggesting a role for FBLN2 in stabilizing the basement membrane (BM). In contrast to mice, in normal adult human breast tissue, FBLN2 was detected in ductal stroma, and in the interlobular stroma, but was not detectable within the lobular regions. In tissue sections of 65 breast cancers FBLN2 staining was lost around malignant cells with retained staining in the neighbouring histologically normal tissue margins. These results are consistent with a role of FBLN2 in mammary epithelial BM stability, and that its down-regulation in breast cancer is associated with loss of the BM and early invasion.

Highlights

  • Breast cancer is one of the most widespread types of cancer in females worldwide and one of the leading causes of cancer-associated deaths[1,2]

  • We further investigated the function of FBLN2 in normal mammary epithelial cells by knocking down FBLN2 in the mouse mammary epithelial cell line EpH4, and assessed its expression in normal and cancerous human breast tissue

  • To investigate a possible role for FBLN2 during mammary epithelial development, we stably transduced FBLN2expressing mammary epithelial EpH4 cells with lentiviral shRNA constructs against Fbln[2] and selected for stable transduction and shRNA expression by puromycin treatment

Read more

Summary

Introduction

Breast cancer is one of the most widespread types of cancer in females worldwide and one of the leading causes of cancer-associated deaths[1,2]. In the mouse mammary gland, FBLN2 has been detected in and around the cap cells of the terminal end buds during puberty in regions where the basement membrane (BM) is formed along the newly developing mammary ductal epithelium, as well as in myoepithelial cells during early pregnancy when the ductal ECM is remodelled to enable lateral branching to occur[10]. This expression pattern indicates a possible role in morphogenesis of the newly formed ducts. Little is known about FBLN2′s role in cancer, though a role in tumour suppression has been suggested by recent studies on nasopharyngeal carcinoma[15], colorectal cancer[16], and in breast cancer cells[17]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call